Stanley A. Schwartz, MD, PhD, UB Distinguished Professor of medicine, pediatrics and microbiology and immunology, has received a $749,000 grant from Kaleida Health to investigate the feasibility of targeting and treating metastasized prostate cancer with nanoparticles.